iHuman Reports Q4 and FY 2025 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 31 2026
0mins
Should l Buy IH?
Source: PRnewswire
- Revenue Decline: For FY 2025, iHuman reported revenues of RMB 807.0 million (approximately USD 115.4 million), a 12.5% decrease from RMB 922.2 million in FY 2024, primarily due to a declining newborn population in China and cautious consumer spending, indicating challenges in the market environment.
- User Engagement Drop: The average monthly active users (MAUs) for Q4 stood at 23.57 million, down 8.6% from 25.78 million in the same period last year, reflecting pressure on user acquisition and retention, necessitating enhanced market strategies to address demographic shifts.
- Cost Control Success: Despite the revenue decline, total operating expenses for FY 2025 were RMB 480.9 million, a 15.4% reduction from RMB 568.2 million in FY 2024, indicating effective cost management that helps maintain profitability amid challenging conditions.
- Special Cash Dividend: The board approved a special cash dividend of USD 0.02 per ordinary share, totaling approximately USD 5.1 million, marking the third consecutive year of such dividends, reflecting the company's structural sustainability and confidence in its financial performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IH
About IH
iHuman Inc is a holding company primarily engaged in the provision of tech-powered, intellectual development products for children. The products primarily include interactive and self-directed apps, offline products and others, as well as animated content and derivative offerings. The interactive and self-directed apps are offered under the brands iHuman bekids and Aha World. The apps primarily include iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHumanpedia, bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, Aha World and Aha Makeover. The Company is also engaged in the development of stimulating materials, including books, interactive materials and smart devices for children. The Company operates its businesses in the domestic market and overseas markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
iHuman Files Annual Report for 2025
- Annual Report Submission: iHuman filed its annual report on Form 20-F for the year ended December 31, 2025, with the U.S. SEC on April 24, 2026, reflecting the company's ongoing commitment to transparency and compliance, ensuring investors have access to the latest financial information.
- Financial Transparency: The annual report includes complete audited financial statements, and iHuman offers to provide hard copies free of charge to shareholders and ADS holders, demonstrating the company's focus on shareholder rights and proactive investor relations.
- Tech-Driven Products: iHuman is dedicated to simplifying the parenting experience through tech-powered intellectual development products, leveraging nearly three decades of industry experience and advanced technological innovations to enhance children's learning interest and capabilities, thereby solidifying its leadership position in the Chinese market.
- Comprehensive Product Suite: The company offers a range of products including self-directed apps, interactive content, and smart devices that cover various areas such as speaking, critical thinking, independent reading, and creativity, aiming to enhance children's learning effectiveness and enjoyment through technological empowerment.
See More
iHuman Files Annual Report for 2025
- Annual Report Submission: iHuman submitted its annual report on Form 20-F for the year ended December 31, 2025, to the SEC on April 24, 2026, enhancing compliance and transparency, which boosts investor confidence.
- Financial Information Access: The company will provide free hard copies of the annual report containing complete audited financial statements to shareholders and ADS holders, further promoting communication and trust with investors.
- Tech-Driven Products: iHuman focuses on tech-powered intellectual development products, leveraging nearly three decades of industry experience and advanced technological innovations to enhance children's learning experiences while alleviating parenting pressures.
- Market Positioning and Vision: By integrating 3D engines, AI/AR functionalities, and big data analysis, iHuman aims to continue delivering efficient and enjoyable intellectual development products for children globally, further solidifying its leadership position in the market.
See More
iHuman Reports Q4 and FY 2025 Financial Results
- Revenue Decline: iHuman's Q4 revenue reached $27.3 million, reflecting a decrease, while FY 2025 revenue was RMB 807 million ($115.4 million), down from RMB 922.2 million in FY 2024, indicating weak market demand.
- Gross Profit Reduction: The gross profit for Q4 was RMB 127.5 million ($18.2 million), down from RMB 156.4 million year-over-year, highlighting pressure on profitability due to rising costs and increased competition.
- Net Income Drop: Q4 net income stood at RMB 15.4 million ($2.2 million), a 41% decline compared to the previous year, suggesting challenges in profitability that may affect future investor confidence.
- User Growth Slowdown: The average monthly active users for Q4 were 23.57 million, a decline from the previous year, indicating a slowdown in user growth that could impact future revenue potential.
See More
iHuman Reports Q4 and FY 2025 Financial Results
- Revenue Decline: For FY 2025, iHuman reported revenues of RMB 807.0 million (approximately USD 115.4 million), a 12.5% decrease from RMB 922.2 million in FY 2024, primarily due to a declining newborn population in China and cautious consumer spending, indicating challenges in the market environment.
- User Engagement Drop: The average monthly active users (MAUs) for Q4 stood at 23.57 million, down 8.6% from 25.78 million in the same period last year, reflecting pressure on user acquisition and retention, necessitating enhanced market strategies to address demographic shifts.
- Cost Control Success: Despite the revenue decline, total operating expenses for FY 2025 were RMB 480.9 million, a 15.4% reduction from RMB 568.2 million in FY 2024, indicating effective cost management that helps maintain profitability amid challenging conditions.
- Special Cash Dividend: The board approved a special cash dividend of USD 0.02 per ordinary share, totaling approximately USD 5.1 million, marking the third consecutive year of such dividends, reflecting the company's structural sustainability and confidence in its financial performance.
See More
iHuman Reports Q3 Revenue of RMB 205.8 Million, Marks 15th Consecutive Quarter of Profitability
- Revenue Performance: iHuman reported Q3 revenues of RMB 205.8 million (approximately $28.9 million), down from RMB 239.4 million in the same period last year, primarily due to a decline in China's newborn population and cautious consumer spending, highlighting challenges in the market environment.
- User Engagement Decline: Average monthly active users (MAUs) stood at 26.13 million, a decrease from 29.12 million year-over-year, reflecting pressure on user growth and the need for enhanced user retention and market expansion strategies.
- Cost Control: The cost of revenues for the quarter was RMB 65.1 million, down from RMB 75.5 million in the prior year, indicating improved operational efficiency, as the company maintained a relatively stable gross margin of 68.3% despite the revenue decline.
- Sustained Profitability: iHuman reported a net income of RMB 21.6 million (approximately $3.0 million), down from RMB 25.1 million year-over-year, yet the achievement of 15 consecutive quarters of profitability demonstrates the company's resilience and potential for sustainable growth in an uncertain market.
See More
iHuman Reports Q3 Revenue of RMB 205.8 Million Amid User Decline
- Revenue Decline: iHuman's Q3 revenue stood at RMB 205.8 million (approximately $28.9 million), reflecting a 14.0% decrease from RMB 239.4 million in the same period last year, primarily due to a declining newborn population and cautious consumer spending in China.
- User Engagement Drop: The average monthly active users (MAUs) for the quarter were 26.13 million, down 10.3% from 29.12 million last year, largely attributed to the reduction in the newborn population affecting user base expansion.
- Sustained Profitability: Despite the revenue drop, iHuman reported its 15th consecutive quarter of profitability with a net income of RMB 21.6 million (approximately $3.0 million), demonstrating robust operational execution and a solid financial foundation.
- Strategic Investment Expansion: The company plans to continue investing in innovation and technology, particularly by expanding its offerings into the smart home ecosystem, aiming to enhance market reach and user touchpoints through partnerships with well-known electric vehicle brand NIO.
See More
iHuman Files Annual Report for 2025
- Annual Report Submission: iHuman filed its annual report on Form 20-F for the year ended December 31, 2025, with the U.S. SEC on April 24, 2026, reflecting the company's ongoing commitment to transparency and compliance, ensuring investors have access to the latest financial information.
- Financial Transparency: The annual report includes complete audited financial statements, and iHuman offers to provide hard copies free of charge to shareholders and ADS holders, demonstrating the company's focus on shareholder rights and proactive investor relations.
- Tech-Driven Products: iHuman is dedicated to simplifying the parenting experience through tech-powered intellectual development products, leveraging nearly three decades of industry experience and advanced technological innovations to enhance children's learning interest and capabilities, thereby solidifying its leadership position in the Chinese market.
- Comprehensive Product Suite: The company offers a range of products including self-directed apps, interactive content, and smart devices that cover various areas such as speaking, critical thinking, independent reading, and creativity, aiming to enhance children's learning effectiveness and enjoyment through technological empowerment.
See More
iHuman Files Annual Report for 2025
- Annual Report Submission: iHuman submitted its annual report on Form 20-F for the year ended December 31, 2025, to the SEC on April 24, 2026, enhancing compliance and transparency, which boosts investor confidence.
- Financial Information Access: The company will provide free hard copies of the annual report containing complete audited financial statements to shareholders and ADS holders, further promoting communication and trust with investors.
- Tech-Driven Products: iHuman focuses on tech-powered intellectual development products, leveraging nearly three decades of industry experience and advanced technological innovations to enhance children's learning experiences while alleviating parenting pressures.
- Market Positioning and Vision: By integrating 3D engines, AI/AR functionalities, and big data analysis, iHuman aims to continue delivering efficient and enjoyable intellectual development products for children globally, further solidifying its leadership position in the market.
See More
iHuman Reports Q4 and FY 2025 Financial Results
- Revenue Decline: iHuman's Q4 revenue reached $27.3 million, reflecting a decrease, while FY 2025 revenue was RMB 807 million ($115.4 million), down from RMB 922.2 million in FY 2024, indicating weak market demand.
- Gross Profit Reduction: The gross profit for Q4 was RMB 127.5 million ($18.2 million), down from RMB 156.4 million year-over-year, highlighting pressure on profitability due to rising costs and increased competition.
- Net Income Drop: Q4 net income stood at RMB 15.4 million ($2.2 million), a 41% decline compared to the previous year, suggesting challenges in profitability that may affect future investor confidence.
- User Growth Slowdown: The average monthly active users for Q4 were 23.57 million, a decline from the previous year, indicating a slowdown in user growth that could impact future revenue potential.
See More
iHuman Reports Q4 and FY 2025 Financial Results
- Revenue Decline: For FY 2025, iHuman reported revenues of RMB 807.0 million (approximately USD 115.4 million), a 12.5% decrease from RMB 922.2 million in FY 2024, primarily due to a declining newborn population in China and cautious consumer spending, indicating challenges in the market environment.
- User Engagement Drop: The average monthly active users (MAUs) for Q4 stood at 23.57 million, down 8.6% from 25.78 million in the same period last year, reflecting pressure on user acquisition and retention, necessitating enhanced market strategies to address demographic shifts.
- Cost Control Success: Despite the revenue decline, total operating expenses for FY 2025 were RMB 480.9 million, a 15.4% reduction from RMB 568.2 million in FY 2024, indicating effective cost management that helps maintain profitability amid challenging conditions.
- Special Cash Dividend: The board approved a special cash dividend of USD 0.02 per ordinary share, totaling approximately USD 5.1 million, marking the third consecutive year of such dividends, reflecting the company's structural sustainability and confidence in its financial performance.
See More
iHuman Reports Q3 Revenue of RMB 205.8 Million, Marks 15th Consecutive Quarter of Profitability
- Revenue Performance: iHuman reported Q3 revenues of RMB 205.8 million (approximately $28.9 million), down from RMB 239.4 million in the same period last year, primarily due to a decline in China's newborn population and cautious consumer spending, highlighting challenges in the market environment.
- User Engagement Decline: Average monthly active users (MAUs) stood at 26.13 million, a decrease from 29.12 million year-over-year, reflecting pressure on user growth and the need for enhanced user retention and market expansion strategies.
- Cost Control: The cost of revenues for the quarter was RMB 65.1 million, down from RMB 75.5 million in the prior year, indicating improved operational efficiency, as the company maintained a relatively stable gross margin of 68.3% despite the revenue decline.
- Sustained Profitability: iHuman reported a net income of RMB 21.6 million (approximately $3.0 million), down from RMB 25.1 million year-over-year, yet the achievement of 15 consecutive quarters of profitability demonstrates the company's resilience and potential for sustainable growth in an uncertain market.
See More
iHuman Reports Q3 Revenue of RMB 205.8 Million Amid User Decline
- Revenue Decline: iHuman's Q3 revenue stood at RMB 205.8 million (approximately $28.9 million), reflecting a 14.0% decrease from RMB 239.4 million in the same period last year, primarily due to a declining newborn population and cautious consumer spending in China.
- User Engagement Drop: The average monthly active users (MAUs) for the quarter were 26.13 million, down 10.3% from 29.12 million last year, largely attributed to the reduction in the newborn population affecting user base expansion.
- Sustained Profitability: Despite the revenue drop, iHuman reported its 15th consecutive quarter of profitability with a net income of RMB 21.6 million (approximately $3.0 million), demonstrating robust operational execution and a solid financial foundation.
- Strategic Investment Expansion: The company plans to continue investing in innovation and technology, particularly by expanding its offerings into the smart home ecosystem, aiming to enhance market reach and user touchpoints through partnerships with well-known electric vehicle brand NIO.
See More
